Neonatal Seizures: An Update on Mechanisms and Management

Clinics in Perinatology

Volumn 36, Issue 4, 2009, Pages 881-900

  Jensen, Frances E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

aminobutyric acid (GABA); Epilepsy; Glutamate; Neurotransmitter receptor; Perinatal; Synapse

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUMETANIDE; CHELERYTHRINE; DIAZEPAM; DOXYCYCLINE; ERYTHROPOIETIN; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; IFENPRODIL; KT 5720; LIDOCAINE; LORAZEPAM; MEMANTINE; MIDAZOLAM; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE; TACROLIMUS; TALAMPANEL; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTICONVULSANT ACTIVITY; BRAIN HYPOXIA; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG RESPONSE; DRUG TARGETING; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; EXTRACORPOREAL OXYGENATION; HUMAN; INCIDENCE; INDUCED HYPOTHERMIA; NERVE CELL EXCITABILITY; NEWBORN DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEIZURE; STROKE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; HUMANS; HYPOTHERMIA, INDUCED; INFANT, NEWBORN; PROGNOSIS; RECEPTORS, NEUROTRANSMITTER; SEIZURES;

EID: 70450196839     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2009.08.001     Document Type: Review

References (134)

1. Scher M.S., Aso K., Beggarly M.E., et al. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics 91 (1993) 128-134
2. Ronen G.M., Penney S., and Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr 134 1 (1999) 71-75
3. Saliba R.M., Annegers J.F., Waller D.K., et al. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol 150 7 (1999) 763-769
4. Tekgul H., Gauvreau K., Soul J., et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics 117 (2006) 1270-1280
5. Volpe J.J. Neurology of the newborn. 5th edition (2008), Saunders/Elsevier, Philadelphia
6. Ronen G.M., Buckley D., Penney S., et al. Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 69 19 (2007) 1816-1822
7. Bergamasco B., Penna P., Ferrero P., et al. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 25 (1984) 131-146
8. Shankaran S., Laptook A.R., Ehrenkranz R.A., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 15 (2005) 1574-1584
9. Gluckman P.D., Wyatt J.S., Azzopardi D., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365 9460 (2005) 663-670
10. + channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology 61 1 (2003) 131-134
11. Singh N.A., Westenskow P., Charlier C., et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 126 Pt 12 (2003) 2726-2737
12. Coppola G., Veggiotti P., Del Giudice E.M., et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy. Brain Dev 28 2 (2006) 76-79
13. Claes L.R., Ceulemans B., Audenaert D., et al. De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 63 11 (2004) 2155-2158
14. Holden K.R., Mellits E.D., and Freeman J.M. Neonatal seizures. I. Correlation of prenatal and perinatal events with outcomes. Pediatrics 70 2 (1982) 165-176
15. McBride M.C., Laroia N., and Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 55 4 (2000) 506-513
16. Glass H.C., Glidden D., Jeremy R.J., et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 155 3 (2009) 318-323
17. Miller S.P., Ramaswamy V., Michelson D., et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 146 4 (2005) 453-460
18. Kohelet D., Shochat R., Lusky A., et al. Risk factors for neonatal seizures in very low birthweight infants: population-based survey. J Child Neurol 19 2 (2004) 123-128
19. Kohelet D., Shochat R., Lusky A., et al. Risk factors for seizures in very low birthweight infants with periventricular leukomalacia. J Child Neurol 21 11 (2006) 965-970
20. Mizrahi E.M., and Kellaway P. Diagnosis and management of neonatal seizures (1998), Lippincott-Raven, Philadelphia
21. Clancy R.R. Prolonged electroencephalogram monitoring for seizures and their treatment. Clin Perinatol 33 3 (2006) 649-665 vi
22. Shellhaas R.A., Soaita A.I., and Clancy R.R. Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics 120 4 (2007) 770-777
23. Lawrence R., Mathur A., Nguyen The Tich S., et al. A pilot study of continuous limited-channel aEEG in term infants with encephalopathy. J Pediatr 154 6 (2009) 835-841 e1
24. Tekgul H., Bourgeois B.F., Gauvreau K., et al. Electroencephalography in neonatal seizures: comparison of a reduced and a full 10/20 montage. Pediatr Neurol 32 3 (2005) 155-161
25. Navakatikyan M.A., Colditz P.B., Burke C.J., et al. Seizure detection algorithm for neonates based on wave-sequence analysis. Clin Neurophysiol 117 6 (2006) 1190-1203
26. Shellhaas R.A., and Clancy R.R. Characterization of neonatal seizures by conventional EEG and single-channel EEG. Clin Neurophysiol 118 10 (2007) 2156-2161
27. Clancy R.R. Summary proceedings from the neurology group on neonatal seizures. Pediatrics 117 3 Pt 2 (2006) S23-S27
28. de Vries L.S., and Toet M.C. Amplitude integrated electroencephalography in the full-term newborn. Clin Perinatol 33 3 (2006) 619-632 vi
29. Grillo E., da Silva R.J., and Barbato Jr. J.H. Pyridoxine-dependent seizures responding to extremely low-dose pyridoxine. Dev Med Child Neurol 43 6 (2001) 413-415
30. Baxter P. Pyridoxine-dependent and pyridoxine-responsive seizures. Dev Med Child Neurol 43 6 (2001) 416-420
31. Grant P.E., and Yu D. Acute injury to the immature brain with hypoxia with or without hypoperfusion. Radiol Clin North Am 44 1 (2006) 63-77 viii
32. Bartha A., Shen J., Katz K.H., et al. Neonatal seizures: multi-center variability in current treatment practices. Pediatr Neurol Res 37 2 (2007) 85-90
33. Sankar R., and Painter M.J. Neonatal seizures: after all these years we still love what doesn't work. Neurology 64 5 (2005) 776-777
34. Booth D., and Evans D.J. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 4 (2004) CD004218
35. Painter M.J., Scher M.S., Stein A.D., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 341 7 (1999) 485-489
36. Boylan G.B., Young K., Panerai R.B., et al. Dynamic cerebral autoregulation in sick newborn infants. Pediatr Res 48 1 (2000) 12-17
37. Carmo K.B., and Barr P. Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. J Paediatr Child Health 41 7 (2005) 313-316
38. Malingre M.M., Van Rooij L.G., Rademaker C.M., et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr 165 9 (2006) 598-604
39. Silverstein F.S., and Ferriero D.M. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 39 2 (2008) 77-79
40. Pellock J. Antiepileptic drugs trials: neonates and infants. Epilepsy Res 68 1 (2006) 42-45
41. Hmaimess G., Kadhim H., Nassogne M.C., et al. Levetiracetam in a neonate with malignant migrating partial seizures. Pediatr Neurol 34 1 (2006) 55-59
42. Jacobs S., Hunt R., Tarnow-Mordi W., et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 4 (2007) CD003311
43. Azzopardi D., Brocklehurst P., Edwards D., et al. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr 8 (2008) 17
44. Rakhade S.N., and Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 5 7 (2009) 380-391
45. Hauser W.A., Annegers J.F., and Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34 (1993) 453-468
46. Aicardi J., and Chevrie J.J. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia 11 2 (1970) 187-197
47. Sanchez R.M., and Jensen F.E. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 42 (2001) 577-585
48. Sanchez R.M., Jensen F.E., Pitanken A., et al. Modeling hypoxia-induced seizures and hypoxic encephalopathy in the neonatal period. Models of seizures and epilepsy (2005), Elsevier, San Diego (CA)
49. Talos D.M., Follett P.L., Folkerth R.D., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 497 1 (2006) 61-77
50. Haynes R.L., Borenstein N.S., DeSilva T.M., et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 484 2 (2005) 156-167
51. Takashima S., Chan F., Becker L.E., et al. Morphology of the developing visual cortex of the human infant: a quantitative and qualitative Golgi study. J Neuropathol Exp Neurol 39 4 (1980) 487-501
52. Huttenlocher P.R., deCourten C., Garey L.J., et al. Synaptogenesis in human visual cortex - evidence for synapse elimination during normal development. Neurosci Lett 33 (1982) 247-252
53. Johnston M.V. Neurotransmitters and vulnerability of the developing brain. Brain Dev 17 5 (1995) 301-306
54. Talos D.M., Fishman R.E., Park H., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J Comp Neurol 497 1 (2006) 42-60
55. Sanchez R.M., Koh S., Rio C., et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 21 20 (2001) 8154-8163
56. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17 (1994) 31-108
57. Jiang Q., Wang J., Wu X., et al. Alterations of NR2B and PSD-95 expression after early-life epileptiform discharges in developing neurons. Int J Dev Neurosci 25 3 (2007) 165-170
58. Wong H.K., Liu X.B., Matos M.F., et al. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J Comp Neurol 450 4 (2002) 303-317
59. Stafstrom C.E., Tandon P., Hori A., et al. Acute effects of MK801 on kainic acid-induced seizures in neonatal rats. Epilepsy Res 26 2 (1997) 335-344
60. Mares P., and Mikulecka A. Different effects of two N-methyl-d-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats. Epilepsy Behav 14 1 (2009) 32-39
61. Chen H.S., Wang Y.F., Rayudu P.V., et al. Neuroprotective concentrations of the N-methyl-d-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86 4 (1998) 1121-1132
62. Ikonomidou C., Bosch F., Miksa M., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
63. Bittigau P., Sifringer M., and Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 993 (2003) 103-114 [discussion: 123-4]
64. Manning S.M., Talos D.M., Zhou C., et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28 26 (2008) 6670-6678
65. Kumar S.S., Bacci A., Kharazia V., et al. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci 22 8 (2002) 3005-3015
66. Talos D.M., Follett P.L., Folkerth R.D., et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 497 1 (2006) 61-77
67. Shank R.P., Gardocki J.F., Streeter A.J., et al. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 Suppl 1 (2000) S3-S9
68. Koh S., Tibayan F.D., Simpson J., et al. NBQX or topiramate treatment following perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45 6 (2004) 569-575
69. Koh S., and Jensen F. Topiramate blocks perinatal hypoxia- induced seizures in rat pups. Ann Neurol 50 3 (2001) 366-372
70. Liu Y., Barks J.D., Xu G., et al. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35 6 (2004) 1460-1465
71. Aujla P.K., Fetell M., and Jensen F.E. Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model. Epilepsia 50 4 (2009) 694-701
72. Swann J.W., Brady R.J., and Martin D.L. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus. Neuroscience 28 3 (1989) 551-561
73. Brooks-Kayal A., Jin H., Price M., et al. Developmental expression of GABA(A) receptor subunit mRNAs in individual hippocampal neurons in vitro and in vivo. J Neurochem 70 3 (1998) 1017-1028
74. Kapur J., and Macdonald R.L. Postnatal development of hippocampal dentate granule cell γ-aminobutyric acid A receptor pharmacological properties. Mol Pharmacol 55 (1999) 444-452
75. Jensen F.E., Alvarado S., Firkusny I.R., et al. NBQX blocks the acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 36 10 (1995) 966-972
76. Swann J., Moshe S.L., Engel Jr. J., et al. Developmental issues in animal models epilepsy: a comprehensive textbook (1997), Lippincott-Raven Publishers, Philadelphia p. 467-80
77. Dzhala V.I., and Staley K.J. Excitatory actions of endogenously released GABA contribute to initiation of ictal epileptiform activity in the developing hippocampus. J Neurosci 23 5 (2003) 1840-1846
78. Khazipov R., Khalilov I., Tyzio R., et al. Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus. Eur J Neurosci 19 3 (2004) 590-600
79. Loturco J.J., Owens D.F., Heath M.J., et al. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15 6 (1995) 1287-1298
80. Owens D.F., Boyce L.H., Davis M.B., et al. Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci 16 20 (1996) 6414-6423
81. Dzhala V.I., Talos D.M., Sdrulla D.A., et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11 11 (2005) 1205-1213
82. Dzhala V.I., Brumback A.C., and Staley K.J. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 63 2 (2008) 222-235
83. Cooper E.C., and Jan L.Y. M-channels: neurological diseases, neuromodulation, and drug development. Arch Neurol 60 4 (2003) 496-500
84. Yue C., and Yaari Y. KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci 24 19 (2004) 4614-4624
85. Pape H.C. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 58 (1996) 299-327
86. Bender R.A., Brewster A., Santoro B., et al. Differential and age-dependent expression of hyperpolarization-activated, cyclic nucleotide-gated cation channel isoforms 1-4 suggests evolving roles in the developing rat hippocampus. Neuroscience 106 4 (2001) 689-698
87. Bender R.A., Galindo R., Mameli M., et al. Synchronized network activity in developing rat hippocampus involves regional hyperpolarization-activated cyclic nucleotide-gated (HCN) channel function. Eur J Neurosci 22 10 (2005) 2669-2674
88. Iwasaki S., Momiyama A., Uchitel O.D., et al. Developmental changes in calcium channel types mediating central synaptic transmission. J Neurosci 20 1 (2000) 59-65
89. Noebels J.L. The biology of epilepsy genes. Annu Rev Neurosci 26 (2003) 599-625
90. Chen Y., Lu J., Pan H., et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 54 2 (2003) 239-243
91. Baram T.Z., and Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21 11 (1998) 471-476
92. Ju W.K., Kim K.Y., and Neufeld A.H. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 77 2 (2003) 137-145
93. Brunson K.L., Eghbal-Ahmadi M., Bender R., et al. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci U S A 98 15 (2001) 8856-8861
94. Brunson K.L., Khan N., Eghbal-Ahmadi M., et al. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol 49 3 (2001) 304-312
95. Ivacko J.A., Sun R., and Silverstein F.S. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 39 1 (1996) 39-47
96. Dommergues M.A., Plaisant F., Verney C., et al. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 3 (2003) 619-628
97. Debillon T., Gras-Leguen C., Leroy S., et al. Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res 145 1 (2003) 39-48
98. Saliba E., and Henrot A. Inflammatory mediators and neonatal brain damage. Biol Neonate 79 3-4 (2001) 224-227
99. Billiards S.S., Haynes R.L., Folkerth R.D., et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 497 2 (2006) 199-208
100. Tikka T., Fiebich B.L., Goldsteins G., et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21 8 (2001) 2580-2588
101. Shapiro L.A., Wang L., and Ribak C.E. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia 49 Suppl 2 (2008) 33-41
102. Vezzani A., Balosso S., and Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22 6 (2008) 797-803
103. Dalmau I., Vela J.M., Gonzalez B., et al. Dynamics of microglia in the developing rat brain. J Comp Neurol 458 2 (2003) 144-157
104. Pfrieger F.W., and Barres B.A. Synaptic efficacy enhanced by glial cells in vitro. Science 277 5332 (1997) 1684-1687
105. Stevens B., Allen N.J., Vazquez L.E., et al. The classical complement cascade mediates CNS synapse elimination. Cell 131 6 (2007) 1164-1178
106. Heo K., Cho Y.J., Cho K.J., et al. Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice. Neurosci Lett 398 3 (2006) 195-200
107. Lechpammer M., Manning S.M., Samonte F., et al. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol 34 4 (2008) 379-393
108. Jantzie L.L., Cheung P.Y., and Todd K.G. Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 25 3 (2005) 314-324
109. Wasterlain C.G., Niquet J., Thompson K.W., et al. Seizure-induced neuronal death in the immature brain. Prog Brain Res 135 (2002) 335-353
110. Stone B.S., Zhang J., Mack D.W., et al. Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol 64 5 (2008) 535-546
111. Kinney H.C., Haynes R.L., Folkerth R.D., et al. White matter lesions in the perinatal period. In: Golden J.A., and Harding B. (Eds). Pathology and genetics: acquired and inherited diseases of the developing nervous system (2004), ISN Neuropathology Press, Basel (Switzerland)
112. Lein E.S., Finney E.M., McQuillen P.S., et al. Subplate neuron ablation alters neurotrophin expression and ocular dominance column formation. Proc Natl Acad Sci U S A 96 23 (1999) 13491-13495
113. Kanold P.O., Kara P., Reid R.C., et al. Role of subplate neurons in functional maturation of visual cortical columns. Science 301 5632 (2003) 521-525
114. McQuillen P.S., Sheldon R.A., Shatz C.J., et al. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 23 8 (2003) 3308-3315
115. Chang Y.S., Mu D., Wendland M., et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58 1 (2005) 106-111
116. Gonzalez F.F., McQuillen P., Mu D., et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29 4-5 (2007) 321-330
117. Mikati M.A., El Hokayem J.A., and El Sabban M.E. Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10. Epilepsia 48 1 (2007) 175-181
118. Ben Ari Y., and Holmes G.L. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 5 12 (2006) 1055-1063
119. Sayin U., Sutula T.P., and Stafstrom C.E. Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia 45 12 (2004) 1539-1548
120. Silverstein F.S., and Jensen F.E. Neonatal seizures. Ann Neurol 62 2 (2007) 112-120
121. Maffei A., and Turrigiano G. The age of plasticity: developmental regulation of synaptic plasticity in neocortical microcircuits. Prog Brain Res 169 (2008) 211-223
122. Rakhade S.N., Zhou C., Aujla P.K., et al. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci 28 32 (2008) 7979-7990
123. Cornejo B.J., Mesches M.H., Coultrap S., et al. A single episode of neonatal seizures permanently alters glutamatergic synapses. Ann Neurol 61 5 (2007) 411-426
124. Stafstrom C.E., Moshe S.L., Swann J.W., et al. Models of pediatric epilepsies: strategies and opportunities. Epilepsia 47 8 (2006) 1407-1414
125. Sanchez R.M., Dai W., Levada R.E., et al. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain. J Neurosci 25 13 (2005) 3442-3451
126. Raol Y.H., Lund I.V., Bandyopadhyay S., et al. Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26 44 (2006) 11342-11346
127. Isaeva E., Isaev D., Khazipov R., et al. Selective impairment of GABAergic synaptic transmission in the flurothyl model of neonatal seizures. Eur J Neurosci 23 6 (2006) 1559-1566
128. Bergey G.K., Swaiman K.F., Schrier B.K., et al. Adverse effects of phenobarbital on morphological and biochemical development of fetal mouse spinal cord neurons in culture. Ann Neurol 9 6 (1981) 584-589
129. Serrano E.E., Kunis D.M., and Ransom B.R. Effects of chronic phenobarbital exposure on cultured mouse spinal cord neurons. Ann Neurol 24 3 (1988) 429-438
130. Pereira de Vasconcelos A., Colin C., Desor D., et al. Influence of early neonatal phenobarbital exposure on cerebral energy metabolism and behavior. Exp Neurol 108 2 (1990) 176-187
131. Schroeder H., Humbert A.C., Koziel V., et al. Behavioral and metabolic consequences of neonatal exposure to diazepam in rat pups. Exp Neurol 131 1 (1995) 53-63
132. Bittigau P., Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 99 23 (2002) 15089-15094
133. Glier C., Dzietko M., Bittigau P., et al. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 187 2 (2004) 403-409
134. Manthey D., Asimiadou S., Stefovska V., et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 193 2 (2005) 497-503